Antibiotic use and the prevalence of antibiotic resistance in bacteria from healthy volunteers in the Dutch community

被引:21
作者
Bruinsma, N
Stobberingh, E
de Smet, P
van den Bogaard, A
机构
[1] Univ Hosp Maastricht, Dept Med Microbiol, NL-6202 AZ Maastricht, Netherlands
[2] WINAp, Inst Pharmaceut Data, The Hague, Netherlands
关键词
D O I
10.1007/s15010-002-3035-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although most antibiotics are consumed in the community (80%), the relation of antibiotic consumption and resistance in the community has not been thoroughly studied. Materials and Methods: In the present study, antibiotic use was related to the prevalence of antibiotic resistance of Escherichia coli and enterococci isolated from healthy volunteers Living in the southern part of the Netherlands in 1996 and 1999. Results: No change in the total antibiotic use in the Dutch community was observed between 1996 and 1999 (3,542 and 3,598 defined daily doses [DDD] per 1,000 inhabitants/year). However, the increased fluoroquinolone use (+ 18%) and the increased prevalence of ciprofloxacin resistance from 0 to 2% is a point of concern, especially since this was accompanied by a significant shift towards higher minimum inhibitory concentration (MIC) values (p < 0.05). A significant decrease in the prevalence of vancomycin-resistant enterococci (p < 0.05) was found in addition to a significant shift towards Lower MIC values for avoparcin, a glycopeptide previously used as growth promoter in animal husbandry (p < 0.05). This was very Likely due to the banning of avoparcin for this purpose from April 1997 onwards. Conclusion: In order to maintain the Low Level of antibiotic use and resistance in The Netherlands, surveillance of antibiotic resistance in nonclinical isolates in relation to antibiotic use is very important.
引用
收藏
页码:9 / 14
页数:6
相关论文
共 35 条
[11]   THE CARRIAGE OF ESCHERICHIA-COLI RESISTANT TO ANTIMICROBIAL AGENTS BY HEALTHY-CHILDREN IN BOSTON, IN CARACAS, VENEZUELA, AND IN QIN-PU, CHINA [J].
LESTER, SC ;
PLA, MD ;
FU, W ;
SCHAEL, IP ;
JIANG, H ;
OBRIEN, TF .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (05) :285-289
[12]   HIGH-FREQUENCY OF ANTIMICROBIAL RESISTANCE IN HUMAN FECAL FLORA [J].
LEVY, SB ;
MARSHALL, B ;
SCHLUEDERBERG, S ;
ROWSE, D ;
DAVIS, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (12) :1801-1806
[13]   Factors impacting on the problem of antibiotic resistance [J].
Levy, SB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (01) :25-30
[14]   ANTIBIOTIC-RESISTANCE OF FECAL ENTEROBACTERIACEAE ISOLATED FROM HEALTHY-VOLUNTEERS, A 15-WEEK FOLLOW-UP-STUDY [J].
LONDON, N ;
NIJSTEN, R ;
VANDERBOGAARD, A ;
STOBBERINGH, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (01) :83-91
[15]   CARRIAGE OF ANTIBIOTIC-RESISTANT ESCHERICHIA-COLI BY HEALTHY-VOLUNTEERS DURING A 15-WEEK PERIOD [J].
LONDON, N ;
NIJSTEN, R ;
VANDERBOGAARD, A ;
STOBBERINGH, E .
INFECTION, 1994, 22 (03) :187-192
[16]   NITROFURANTOIN - MECHANISM OF ACTION AND IMPLICATIONS FOR RESISTANCE DEVELOPMENT IN COMMON UROPATHOGENS [J].
MCOSKER, CC ;
FITZPATRICK, PM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 :23-30
[17]  
MELLON N, 2001, HOGGING IT ESTIMATES
[18]  
National Committee for Clinical Laboratory Studies, 1998, PERF STAND ANT SUSC
[19]   RESISTANCE IN FECAL ESCHERICHIA-COLI ISOLATED FROM PIGFARMERS AND ABATTOIR WORKERS [J].
NIJSTEN, R ;
LONDON, N ;
VANDENBOGAARD, A ;
STOBBERINGH, E .
EPIDEMIOLOGY AND INFECTION, 1994, 113 (01) :45-52
[20]   A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora [J].
Österblad, M ;
Hakanen, A ;
Manninen, R ;
Leistevuo, T ;
Peltonen, R ;
Meurman, O ;
Huovinen, P ;
Kotilainen, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1479-1484